SCHEMBL16975604

SCHEMBL16975604

CNCc1ccc(-c2nnc(-c3cc(-c4ccc([S+]([O-])C5CCCC5)cc4)cnc3N)o2)cc1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 10/20 0.45
▸ ATR Q13535 10/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310892 0.90 ATR (0.46) LRRK2ATR
SCHEMBL13138319 0.78 ATR (0.60) ATR
SCHEMBL2640894 0.77 CHEK2 (0.50) LRRK2ATR
SCHEMBL2640812 0.76 ATR (0.54) ATR
SCHEMBL10277222 0.76 ATR (0.48) LRRK2ATR
SCHEMBL17034569 0.76 ATR (0.48) LRRK2ATR
SCHEMBL10310876 0.75 ATR (0.41) ATR
SCHEMBL13138347 0.74 ATR (0.53) ATR
SCHEMBL16975605 0.74 ATR (0.44) LRRK2ATR
SCHEMBL13138296 0.74 ATR (0.63) ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096584-B2 Compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-08-04 — — US disclosed
Send feedback